Efficacy and safety of galacto-oligosaccharide in the treatment of functional constipation: randomized clinical trial.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jae-Hwan | - |
dc.contributor.author | Kim, Geun-Bae | - |
dc.contributor.author | Han, Kisoo | - |
dc.contributor.author | Jung, Eun-Jin | - |
dc.contributor.author | Suh, Hyung Joo | - |
dc.contributor.author | Jo, Kyungae | - |
dc.date.accessioned | 2024-06-14T05:30:33Z | - |
dc.date.available | 2024-06-14T05:30:33Z | - |
dc.date.issued | 2024-06 | - |
dc.identifier.issn | 2042-650X | - |
dc.identifier.issn | 2042-6496 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74180 | - |
dc.description.abstract | The efficacy and safety of galacto-oligosaccharides (GOS) in treating functional constipation were evaluated in a four-week randomized, double-blind clinical trial on 63 patients who met Rome IV criteria (34 GOS, 29 placebo group). The number of bowel movements per day and changes in the shape of bowel movements in the treatment group significantly improved compared to those in the control group after four weeks. The Patient Assessment Constipation Quality of Life questionnaire showed that satisfaction with constipation significantly increased in the treatment group. The levels of Bifidobacterium sp. and Lactobacillus sp. significantly increased after four weeks of GOS treatment compared to those measured at baseline. No significant adverse drug reactions were identified in any indicator except for pulse rate. Thus, the prebiotic GOS can be safely used in foods and pharmaceuticals to alleviate symptoms of functional constipation by improving the intestinal flora. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.title | Efficacy and safety of galacto-oligosaccharide in the treatment of functional constipation: randomized clinical trial. | - |
dc.type | Article | - |
dc.identifier.doi | 10.1039/d4fo00999a | - |
dc.identifier.bibliographicCitation | Food & function, v.15, no.12, pp 6374 - 6382 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 001230434200001 | - |
dc.identifier.scopusid | 2-s2.0-85194062140 | - |
dc.citation.endPage | 6382 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 6374 | - |
dc.citation.title | Food & function | - |
dc.citation.volume | 15 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | IRRITABLE-BOWEL-SYNDROME | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | GUT MICROBIOTA | - |
dc.subject.keywordPlus | PARALLEL-GROUP | - |
dc.subject.keywordPlus | HEALTH | - |
dc.subject.keywordPlus | PROBIOTICS | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordPlus | TRANSIT | - |
dc.subject.keywordPlus | GALACTOOLIGOSACCHARIDES | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Food Science & Technology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Food Science & Technology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.